3,4,5-Tricaffeoylquinic acid°¡ ÆÄŲ½¼ÁõÈıº À¯¹ßµ¶¼Ò 1-methyl-4-phenylpyridinium¿¡ ÀÇÇÑ ¼¼Æ÷ÀÚ¸ê»ç¿¡ ¹ÌÄ¡´Â ¾ïÁ¦È¿°ú
Inhibitory Effect of 3,4,5-Tricaffeoylquinic Acid on Parkinsonian Toxin 1-Methyl-4-phenylpyridinium-induced Apoptosis

´ëÇѽŰæ°úÇÐȸÁö 2014³â 32±Ç 2È£ p.72 ~ p.81

ÁÖÀçÁ¤(Joo Jae-Jeong) - Áß¾Óº¸Èƺ´¿ø ½Å°æ°ú
°­ÁøÈ£(Kang Jin-Ho) - Áß¾Óº¸Èƺ´¿ø ½Å°æ°ú
ÇÑÁ¤È£(Han Jeong-Ho) - Áß¾Óº¸Èƺ´¿ø ½Å°æ°ú
±èµÎÀÀ(Kim Doo-Eung) - Áß¾Óº¸Èƺ´¿ø ½Å°æ°ú
ÀÌÁ¤¼ö(Lee Chung-Soo) - Áß¾Ó´ëÇб³ Àǰú´ëÇÐ ¾à¸®Çб³½Ç

Abstract

Background: 1-Methyl-4-phenylpyridinium (MPP + ) causes a neuronal cell injury that is similar to the findings observed in Parkinson¡¯s disease. Caffeoylquinic acid derivatives have demonstrated anti-oxidant and anti-inflammatory effects. Nevertheless, the effect of 3,4,5-tricaffeoylquinic acid (3,4,5-triCQA) on the neuronal cell death due to exposure of parkinsonian toxin MPP + remains unclear.

Methods: Using differentiated PC12 cells, the preventive effect of 3,4,5-triCQA on the MPP + -induced cell death in relation to apoptotic process was examined.

Results: MPP + induced a decrease in Bid, Bcl-2 and survivin protein levels, increase in Bax levels, loss of the mitochondrial transmembrane potential, cytochrome c release, activation of caspases (-8, -9 and -3), cleavage of PARP-1, and an increase in the tumor suppressor p53 levels. 3,4,5-Tricaffeoylquinic acid attenuated the MPP + -induced changes in the apoptosis-related protein levels, formation of reactive oxygen species, depletion of GSH, nuclear damage and cell death. 3,4,5-Tricaffeoylquinic acid attenuated another parkinsonian neurotoxin rotenone-induced cell death.
Conclusions: 3,4,5-Tricaffeoylquinic acid may attenuate the MPP + -induced apoptosis in PC12 cells by suppressing the activation of the mitochondrial pathway and the caspase-8- and Bid-dependent pathways. The preventive effect seems to be ascribed to its inhibitory effect on the formation of reactive oxygen species and depletion of GSH. Key Words: 3,4,5-Tricaffeoylquinic acid, 1-Methyl-4-phenylpyridinium, PC12 cells, Apoptosis-related proteins, Protection

Ű¿öµå

3,4,5-Tricaffeoylquinic acid, 1-Methyl-4-phenylpyridinium, PC12 cells, Apoptosis-related proteins, Protection
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå